Want to see HK:1789 full AI Analyst Report?
1789 Stock Chart & Stats
HK$5.91
-HK$0.05(-1.15%)
At close: 4:00 PM EST
HK$5.91
-HK$0.05(-1.15%)
Day’s Range― - ―
52-Week RangeHK$4.75 - HK$7.15
Previous CloseN/A
Volume3.85M
Average Volume (3M)4.30M
Market Cap
HK$6.64B
Enterprise ValueHK$4.91K
Total Cash (Recent Filing)HK$1.47B
Total Debt (Recent Filing)HK$144.79M
Price to Earnings (P/E)16.9
Beta1.05
Next Earnings
Aug 26, 2026EPS Estimate
0.2Next Dividend Ex-DateN/A
Dividend Yield2%
Share Statistics
EPS (TTM)0.30
Shares Outstanding1,125,469,700
10 Day Avg. Volume3,969,892
30 Day Avg. Volume4,297,109
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)1.97
Price to Sales (P/S)3.87
P/FCF Ratio18.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.37
Revenue Forecast (FY)HK$1.65B
Bulls Say, Bears Say
Bulls Say
Strong ProfitabilityHigh gross, operating, and net margins indicate pricing power, product value, and disciplined cost management. Sustained profitability provides internal funding for research, product development, and commercial expansion in orthopedic implants.
Conservative Balance SheetVery low leverage reduces financial risk and interest burden, giving AK Medical flexibility to invest through industry cycles. Growing equity and assets also strengthen resilience as the company expands its orthopedic device platform.
Positive Free Cash FlowPositive operating and free cash flow demonstrates that the business can convert earnings into funds for investment, debt avoidance, and shareholder returns. The year-on-year free-cash-flow increase supports the durability of current operations.
Bears Say
Cash-Flow VolatilityThe sharp historical deterioration shows that reported profitability does not always translate consistently into cash. Such volatility can constrain investment planning and may reflect working-capital or procurement-related pressures.
Uneven Revenue GrowthRecent growth is positive but moderate, and the uneven historical pattern indicates exposure to hospital procurement cycles, tendering, and product adoption. This makes sustained expansion less predictable than the strong margins suggest.
Moderate Cash ConversionCash conversion below net income means some reported earnings remain tied up in non-cash items or working capital. If this persists, internally generated funds may be less available for innovation, capacity growth, or distributions.
AK Medical Holdings Ltd. News
1789 FAQ
What was AK Medical Holdings Ltd.’s price range in the past 12 months?
AK Medical Holdings Ltd. lowest stock price was HK$4.75 and its highest was HK$7.15 in the past 12 months.
What is AK Medical Holdings Ltd.’s market cap?
AK Medical Holdings Ltd.’s market cap is HK$6.64B.
When is AK Medical Holdings Ltd.’s upcoming earnings report date?
AK Medical Holdings Ltd.’s upcoming earnings report date is Aug 26, 2026 which is in 3 days.
How were AK Medical Holdings Ltd.’s earnings last quarter?
AK Medical Holdings Ltd. released its earnings results on Mar 25, 2026. The company reported HK$0.187 earnings per share for the quarter, beating the consensus estimate of HK$0.175 by HK$0.012.
Is AK Medical Holdings Ltd. overvalued?
According to Wall Street analysts AK Medical Holdings Ltd.’s price is currently Overvalued.
Does AK Medical Holdings Ltd. pay dividends?
AK Medical Holdings Ltd. pays a Annually dividend of HK$0.118 which represents an annual dividend yield of 2%. See more information on AK Medical Holdings Ltd. dividends here
What is AK Medical Holdings Ltd.’s EPS estimate?
AK Medical Holdings Ltd.’s EPS estimate is 0.2.
How many shares outstanding does AK Medical Holdings Ltd. have?
AK Medical Holdings Ltd. has 1,125,469,700 shares outstanding.
What happened to AK Medical Holdings Ltd.’s price movement after its last earnings report?
AK Medical Holdings Ltd. reported an EPS of HK$0.187 in its last earnings report, beating expectations of HK$0.175. Following the earnings report the stock price went up 2.634%.
Which hedge fund is a major shareholder of AK Medical Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:1789
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
AK Medical Holdings Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
26.55%
12-Months-Change
Fundamentals
Return on Equity
2.00%
Trailing 12-Months
Asset Growth
14.93%
Trailing 12-Months
Company Description
AK Medical Holdings Ltd.
AK Medical Holdings Limited, an investment holding enterprise, specializes in the research, development, production, and worldwide commercialization of orthopedic joint implants and related medical devices under the AK Medical brand. Its comprehensive product offerings encompass conventional knee, hip, and spine replacement implants, as well as advanced 3D-printed solutions like hip implants, artificial vertebral bodies, and spinal interbody cages. The company further expands its operations by distributing orthopedic products from third-party manufacturers and by fabricating surgical instruments and medical irrigators. Its diverse client base spans distributors, hospitals, physicians, surgeons, and directly serves patients. Established in Beijing, People's Republic of China, in 2003, AK Medical Holdings Limited functions as a subsidiary of Ximalaya Limited.
Technical Analysis
MicroPort Scientific
―
LifeTech Scientific Corporation
―
MicroPort CardioFlow Medtech Corp.
―
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
―
Venus Medtech (Hangzhou), Inc. Class H
―